Nelfinavir-Resistant, Amprenavir-Hypersusceptible Strains of Human Immunodeficiency Virus Type 1 Carrying an N88S Mutation in Protease Have Reduced Infectivity, Reduced Replication Capacity, and Reduced Fitness and Process the Gag Polyprotein Precursor Aberrantly

The evolution of human immunodeficiency virus type 1 (HIV-1) strains with reduced susceptibility to protease inhibitors (PIs) is a major cause of PI treatment failure. A subset of subjects failing a therapy regimen containing the PI nelfinavir developed mutations at position 88 in the protease regio...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	J Virol
Egile Nagusiak:	Resch, Wolfgang, Ziermann, Rainer, Parkin, Neil, Gamarnik, Andrea, Swanstrom, Ronald
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 2002
Gaiak:	Vaccines and Antiviral Agents
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC136408/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12163585/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.76.17.8659-8666.2002
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!